These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27593690)

  • 1. The Application of Amino Acids in Freeze Dried Protein Formulations.
    Stärtzel P
    PDA J Pharm Sci Technol; 2016 Sep; ():. PubMed ID: 27593690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations.
    Thakral S; Sonje J; Munjal B; Suryanarayanan R
    Adv Drug Deliv Rev; 2021 Jun; 173():1-19. PubMed ID: 33741437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
    Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
    Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development.
    Liu J
    Pharm Dev Technol; 2006 Feb; 11(1):3-28. PubMed ID: 16544906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of formulation variables on the stability of freeze-dried human growth hormone.
    Pikal MJ; Dellerman KM; Roy ML; Riggin RM
    Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates.
    Grant Y; Matejtschuk P; Dalby PA
    Biotechnol Bioeng; 2009 Dec; 104(5):957-64. PubMed ID: 19530082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.
    Fang WJ; Qi W; Kinzell J; Prestrelski S; Carpenter JF
    Pharm Res; 2012 Dec; 29(12):3278-91. PubMed ID: 22766900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion into sugar matrices.
    Izutsu K; Yoshioka S; Kojima S
    Pharm Res; 1995 Jun; 12(6):838-43. PubMed ID: 7667187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Excipients on Freeze-dried Monoclonal Antibody Formulation Degradation and Sub-Visible Particle Formation during Shaking.
    Jin MJ; Ge XZ; Huang Q; Liu JW; Ingle RG; Gao D; Fang WJ
    Pharm Res; 2024 Feb; 41(2):321-334. PubMed ID: 38291165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved water dispersibility and photostability in folic acid nanoparticles with transglycosylated naringin using combined processes of wet-milling and freeze-drying.
    Semba K; Kadota K; Arima H; Nakanishi A; Tandia M; Uchiyama H; Sugiyama K; Tozuka Y
    Food Res Int; 2019 Jul; 121():108-116. PubMed ID: 31108730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.